The new way to find
Alzheimer’s cures
Reprogramming Alzheimer Patient Cells
Cell Invent develops new human disease models based on reprogrammed Alzheimer patient cells. Based on our findings we are developing phenotype-based screening methods.
They also strengthen drug development by providing tools to assess treatment response and prioritize candidates for continued development. In addition, our work may contribute to companion diagnostics development through the identification of phenotypic and molecular signatures that can support patient selection and more targeted therapeutic approaches.
Drug Discovery
Identify new candidates faster and with greater precision using human, phenotypic disease models that reflect Alzheimer’s in a more clinically relevant way.
Drug Development
Advance the development of new therapies with patient-relevant cell models that provide stronger decision support and increase the likelihood of clinical success.
Companion Diagnostics Development
Develop the next generation of companion diagnostics using biologically relevant patient models.